EUVIMEDEUVIMED entdecken
Crossref

GLP-1 receptor agonists in addiction therapy

Nora D Volkow, Eric M Wargo

Science · 05.11.2026 · 394 (6824) · 610-611

DOI: 10.1126/science.aej9836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 05.11.2026. Verfasst von Nora D Volkow und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Institute on Drug Abuse, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Behavior, Addictive, Glucagon-Like Peptide 1, Glucagon-Like Peptide-1 Receptor Agonists, Substance-Related Disorders. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Use of GLP-1–based therapies for addiction could provide a bridge toward whole-person health care

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behavior, AddictiveGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsSubstance-Related DisordersHumansExenatideGlucagon-Like Peptide-1 Receptor

Substanzen

ExenatideGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • National Institute on Drug Abuse, Bethesda, MD, USA.

Zitieren

APA

Volkow, N. D., & Wargo, E. M. (2026). GLP-1 receptor agonists in addiction therapy. Science, 394(6824), 610-611. https://doi.org/10.1126/science.aej9836

Vancouver

Volkow ND, Wargo EM. GLP-1 receptor agonists in addiction therapy. Science. 2026;394(6824):610-611. doi:10.1126/science.aej9836

BibTeX
@article{Volkow2026,
  author = {Volkow, Nora D and Wargo, Eric M},
  title = {GLP-1 receptor agonists in addiction therapy},
  journal = {Science},
  year = {2026},
  volume = {394},
  number = {6824},
  pages = {610--611},
  doi = {10.1126/science.aej9836}
}
Kostenlos starten →